Sacks, S.A., Schwartz, B.L., & Mueser, K.T. (2016). “A pilot study of the trauma recovery group for veterans with posttraumatic stress disorder and co-occurring serious mental illness.” Journal of Mental Health (epub ahead of publication) http://dx.doi.org/10.1080/09638237.2016.1222057
Deutsch, S., Schwartz, B.L., Urbano, M., Burket, J., Benson A., & Herndon A. (2014). “Nicotinic acetylcholine receptors in autism spectrum disorders: Therapeutic implications.” In: The Comprehensive Guide to Autism, Patel , V., Preedy, V., Martin, C. (eds.) Springer-Verlag Berlin Heidelberg.
Deutsch, S.I., Schwartz, B.L., Schooler, N.R., Brown, C.H., Rosse, R.B., & Rosse, S.M. (2013). “Targeting alpha-7 nicotinic neurotransmission in schizophrenia: A novel agonist strategy.” Schizophrenia Research 148, 138–144. PMCID: PMC3732552
Schwartz, B.L., Vaidya, C.V., Shook, D., & Deutsch, S.I. (2013). “Neural basis of implicit memory for socio-emotional information in schizophrenia.” Psychiatry Research 206, 173–180. PMCID: PMC3586761
Schwartz, B.L., Vaidya, C.V., Howard, J.H., Jr., & Deutsch, S.I. (2010). “Attention to gaze and emotion in schizophrenia.” Neuropsychology 24(6), 711-720.
Katz, E.U., Burket, J.A., Rosse, S.M., Rosse, R.B., Schwartz, B.L. & Deutsch, S.I. (2010). “Cerebral ventricular asymmetry and ventriculomegaly interact to increase risk for schizophrenia: A case report and recommendation for routine fetal sonography.” CNS Spectrums 15(9), 522-526
Schwartz, B.L., Parker, E.S., Rosse, R.B. & Deutsch, S.I. (2009). “Recognition memory probes affect what is remembered in schizophrenia.” Psychiatry Research 167, 21–27.
Henry, J.W., Neptune, D., Chapman, J.C., Schwartz, B.L., Rosse, R.B., & Deutsch, S.I. (2008). “The sailor who won’t follow orders.” Current Psychiatry 7, 57-61.
Deutsch, S.I., Rosse, R.B., Schwartz, B.L., Schooler, N.R., Gaskins, B.L., Long, K.D. & Mastropaolo J. (2008). “Effects of CDP-Choline and the combination of CDP-Choline and Galantamine differ in an animal model of schizophrenia: Development of a selective α7 nicotinic acetylcholine receptor agonist strategy.” European Neuropsychopharmacology 18, 147-151.
Deutsch, S.I., Schwartz, B.L., Schooler N.R., Rosse, R.B., Mastropaolo, J, & Gaskins, B. (2008). “First administration of cytidine diphosphocholine and galantamine in schizophrenia: A sustained alpha7 nicotinic agonist strategy.” Clinical Neuropharmacology 31, 34-39.
Deutsch, S.I., Rosse, R.B. & Schwartz, B.L. (2007). “Williams Syndrome: A genetic deletion disorder presenting clues to the biology of sociability and clinical challenges of hypersociability.” CNS Spectrums, 12(12): 903-909.
Schwartz, B.L., Mastropaolo, J., Rosse, R.B., Mathis, G. & Deutsch, S.I. (2006). “Imitation of facial expression in schizophrenia.” Psychiatry Research, 145, 87-94.
Marvel, C.L., Schwartz, B.L., Howard, D.V. & Howard, J.H., Jr. (2005). “Implicit learning of non-spatial sequences in schizophrenia.” Journal of the International Neuropsychological Society, 11, 659-667.
Soderlund, H., Parker, E.S., Schwartz, B.L. & Tulving, E. (2005). “Memory encoding and retrieval on the ascending and descending limbs of the blood alcohol concentration curve.” Psychopharmacology (Berl),182(2), 305-17.
Parker, E.S., Landau, S.M., Whipple, S.C. & Schwartz, B.L. (2004). “Aging, recall and recognition: Norms for the University of Southern California Repeatable Episodic Memory Test.” Journal of Clinical and Experimental Neuropsychology, 26, 428-440.
Marvel, C.L., Schwartz, B.L. & Isaacs, K. (2004). “Word production deficits in schizophrenia.” Brain & Language, 89(1), 182-191.